Laboratory Based Test For Gonorrhoea

Last updated:

By Steve Page

There are several laboratory based tests for the detection of N. gonorrhoea, such as the Nucleic acid probe test, Gram stain, Monoclonal antibody and the isothermal amplification system. Each one has advantages and disadvantages. Listed below are the main ones:

Nucleic acid probe test

A laboratory-based screening test for gonorrhoea consists of PCR assays. These tests increase the chances of detection of gonorrhoea, but they are not 100% accurate.

In the absence of culture, the test cannot detect gonorrhoea in specimens with mucosal cells. Patients with gonococcemia usually have elevated white blood cell counts and erythrocyte sedimentation rate (ESR), though the ESR is usually only mildly elevated.

There are several advantages of the Cobas assay. Its sensitivity and specificity are similar to other test methods. The test can detect N. gonorrhoea in 73% of men and 98% of women. The Cobas assay is more sensitive than AC2 or CTQ/GTQ tests and can be used in both women and men. However, it is not specific enough for use in all cases.

The Cobas assay was evaluated for its sensitivity and specificity in both C. trachomatis and N. gonorrhoea, and has been approved by the Food and Drug Administration. This test is currently in use by physicians and health care providers worldwide but is a valuable tool in public health programs. The Cobas assay can also be used in laboratories for clinical screening.

The results of the study were very positive. The Cobas CT/NG assay was developed for the Cobas 6800/8800 systems. It was used for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae, and its results were compared with those of nucleic acid amplification tests and clinical examination.

Gram stain

The preferred laboratory test for gonorrhoea diagnosis is a gram stain, which is a visual test that can identify the bacterium present.

In addition, the test is useful for antimicrobial susceptibility testing and for identifying outbreaks and determining the efficacy of treatments. The results of a Gram stain are preliminary and may require further testing to confirm the diagnosis.

Cultures from mucosal sites, such as the urethra, cervix, and rectum, yield the highest concentration of N gonorrhoeae organisms. However, these smears are not as sensitive as cervical or urethral cultures.

Additionally, these cultures may contain non-specific strains of Acinetobacter species and Kingella denitrificans. The sensitivity of both tests depends on the quality of the sample and the experience of the microscopist. However, in places where gonorrhoea is not common, it would be impractical to use swabs from these tissues.

A positive gram stain culture is a laboratory-based test that determines whether the infection is sporadic or chronic. It is also helpful for determining whether an infection has a definite cause since it can be caused by an environmental source. The gram stain test is commonly used for diagnosing gonorrhoea and is the most common laboratory test for gonorrhoea. However, this method is not recommended for the diagnosis of gonorrhoea in children.

In the US, there is a fully automated test for gonorrhoea that uses a PCR system. The test uses a chemiluminescent-labelled single-strand DNA probe that binds to the ribosomal RNA of N gonorrhoea. The result is a phosphorescent ring detected with a luminometer. It has better sensitivity than other laboratory-based tests.

The laboratory-based test for gonorrhoea is often performed in conjunction with other tests. If the organisms can grow on culture, it is a good indicator that the organism is infected with gonorrhoea. However, it is not a fool-proof test for gonorrhoea. A high ratio of Gram stain-positive to culture-negative results may indicate inhibitory effects on the culture medium.

Monoclonal antibody

A laboratory based screen for gonorrhoea is a highly sensitive test that can be used in clinical settings. This test requires that the isolates be viable and susceptible to the antibiotics tested.

The results of the screen can be used to assess the effectiveness of current treatment regimens and investigate treatment failures. The report highlights the importance of culture capability in detecting N. gonorrhoea and C. trachomatis.

Monoclonal antibodies used in this test can distinguish among a wide variety of strains. Its specificity increases with higher concentrations of monoclonal antibodies and is more sensitive than culture-based methods.

However, it is not 100% sensitive and specific. This means that it may take more than one test to confirm a diagnosis. A laboratory based screen for gonorrhoea using monoclonal antibodies can be useful for clinical diagnosis and epidemiological studies.

The current CDC report updates its 2002 recommendations for screening tests for gonorrhoea. It includes new recommendations on the type of specimen that should be tested, when supplemental testing is necessary, and when it is not necessary.

The recommendations are intended for laboratory staff, clinicians, and disease control personnel. So, if you are planning to use a monoclonal antibody for gonorrhoea screening, be sure to follow these recommendations.

In most cases, N gonorrhoeae are detected by culture or a non-culture detection test. Cultures need mucous-containing tissue to be successful. The non-culture test is less accurate when the specimen is blood or menstrual fluid-containing, or when it is taken during menstruation. Moreover, the test requires that the specimen be warm enough to avoid contamination.

The most reliable and sensitive N gonorrhoeae organisms can be detected from mucosal sites, such as the urethra and cervix. Typically, urethral cultures yield the highest yield. Blood cultures and joint fluid cultures produce similar results but are not as effective. Skin lesions can be a suitable alternative for testing if N gonorrhoeae is suspected.

Isothermal amplification system

A new Isothermal amplification system for gonorrhoea screening method has been developed to detect the invasive bacterium Neisseria gonorrhoeae.

It uses a polymer nanoparticle-based biosensor and loop-mediated isothermal amplification. For this test, the target DNA is incubated in a 25-ml reaction system, containing 1ml DNA template, 0.4 and 1.6 mM inner primers, and loop primers. The standard procedure includes a final step, including a positive and negative control, before the results are reported.

Current laboratory-based methods rely on expensive and bulky instruments for detection. The high cost and complexity of PCR-based techniques make them impractical and unreliable.

New technologies for isothermal amplification will facilitate the development of more cost-effective, compact point-of-care diagnostics. Several proof-of-concept studies have reported similar sensitivity and specificity, as well as rapidness. However, more research is needed to validate and confirm these promising diagnostic characteristics.

A rapid method of detecting N. gonorrhoeae from genital secretion samples has several advantages. It is low-cost, sensitive, and specific. In addition, it is easy to use and can be used in many settings, including low-resource regions. It is also possible to perform rapid diagnostics without the need for specialized labs or equipment.

Molecular amplification is a method based on strand-displacing DNA polymerase. The method uses homologous strands of DNA to achieve amplification.

The DNA is paired with an enzyme to produce amplification products. After the primers have been incubated for several hours, the polymerase will reapply the strands in a circular pattern.